Formestane

  Cat. No.:  DC9045  
Chemical Structure
566-48-3
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Formestane(CGP-32349; 4-OHA) is a selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer.
Cas No.: 566-48-3
SMILES: OC1C(=O)CCC2(C)C=1CCC1C2CCC2(C)C1CCC2=O
Formula: C19H26O3
M.Wt: 302.41
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Formestane(CGP-32349; 4-OHA) is a selective, type I, steroidal aromatase inhibitor used in the treatment of estrogen-receptor positive breast cancer.Formestane (Lentaron) is a type I, steroidal aromatase inhibitor. formestane is an effective and well tolerated addition to the therapeutic options available for the treatment of postmenopausal women with advanced breast cancer. Formestane (4-hydroxyandrostenedione) is an aromatase inhibitor which significantly reduces plasma levels of estrogen and has shown antitumour activity in postmenopausal women with breast cancer. Formestane is well tolerated by the majority of patients; adverse events rarely necessitate cessation of therapy. Formestane is effective and well tolerated as first-line endocrine therapy for advanced disease.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
X